Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$5,352 Mln
Revenue (TTM)
$3,010 Mln
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
1.1 %
P/E Ratio
37.4
P/B Ratio
1.3
Industry P/E
73.01
EV/EBITDA
12.5
Div. Yield
1.1 %
Debt to Equity
0.4
Book Value
$--
EPS
$3.2
Face value
--
Shares outstanding
44,189,000
CFO
$4,233.25 Mln
EBITDA
$6,202.22 Mln
Net Profit
$3,024.88 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Teleflex (TFX)
| -33.9 | -8.9 | -15.8 | -42.8 | -21.7 | -20.4 | -1.2 |
|
BSE Sensex*
| 4.0 | -1.2 | 8.0 | 5.3 | 16.6 | 18.9 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Teleflex (TFX)
| -28.4 | -0.1 | -24.0 | -20.2 | 9.3 | 45.6 | 3.9 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Teleflex (TFX)
|
117.7 | 5,351.7 | 3,010.1 | 149.4 | 10.1 | 3.5 | 37.4 | 1.3 |
| 13.3 | 8,960.8 | 6,685.2 | 715.6 | 16.4 | 12.3 | 12.6 | 1.5 | |
| 250.1 | 6,628.2 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 232.0 | 6,318.9 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 0.9 | |
| 38.4 | 5,921.9 | 3,446.1 | 79.6 | 7.5 | 4.4 | 73.7 | 3.2 | |
| 57.4 | 7,968.4 | 2,510.8 | 185.6 | 8.8 | 4.5 | 43.7 | 1.9 | |
| 71.1 | 8,845.4 | 12,669.0 | 407.0 | 5.4 | 11.8 | 22 | 2.7 | |
| 162.8 | 8,812.8 | 1,973.6 | -494.5 | -11.4 | -41 | -- | 9.3 | |
| 257.0 | 10,106.3 | 1,240.1 | 42.2 | 4.1 | 3.6 | 243.8 | 8.2 | |
| 117.5 | 7,084.1 | 645.7 | -25.4 | 6.8 | -1.3 | -- | 3.6 |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise... Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania. Address: 550 East Swedesford Road, Wayne, PA, United States, 19087-1603 Read more
Chairman, President & CEO
Mr. Liam J. Kelly
Corporate VP & President of Global Commercial
Mr. Jay White
Headquarters
Wayne, PA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Teleflex Incorporated (TFX) stood at $ 7,839 Mln as on 31-Mar-25
The share price of Teleflex Incorporated (TFX) is $117.72 (NYSE) as of 18-Jun-2025 16:10 EDT. Teleflex Incorporated (TFX) has given a return of -21.67% in the last 3 years.
Teleflex Incorporated (TFX) has a market capitalisation of $ 5,352 Mln as on 18-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Teleflex Incorporated (TFX) is 1.31 times as on 18-Jun-2025, a 64% discount to its peers’ median range of 3.61 times.
The P/E ratio of Teleflex Incorporated (TFX) is 37.43 times as on 18-Jun-2025, a 49% discount to its peers’ median range of 73.01 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Teleflex Incorporated (TFX) and enter the required number of quantities and click on buy to purchase the shares of Teleflex Incorporated (TFX).
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania. Address: 550 East Swedesford Road, Wayne, PA, United States, 19087-1603
The CEO & director of Mr. Liam J. Kelly. is Teleflex Incorporated (TFX), and CFO & Sr. VP is Mr. Jay White.
There is no promoter pledging in Teleflex Incorporated (TFX).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
981
|
|
|
921
|
|
|
906
|
|
|
889
|
|
|
823
|
|
|
742
|
|
|
671
|
|
|
671
|
|
|
602
|
| Teleflex Incorporated (TFX) | Ratios |
|---|---|
|
Return on equity(%)
|
3.48
|
|
Operating margin(%)
|
10.07
|
|
Net Margin(%)
|
4.96
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Teleflex Incorporated (TFX) was $0 Mln.
$0.19
(
